Intellectual Property Cases
Cases 11 - 16 of 16
VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. SLAYBACK PHARMA, LLC et al
as 3:2019cv08218
Defendant: SLAYBACK PHARMA INDIA LLP and SLAYBACK PHARMA, LLC
Plaintiff: KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS NORTH AMERICA LLC and others
Cause Of Action: 35 U.S.C. § 271
KYTHERA BIOPHARMACEUTICALS, INC. v. SLAYBACK PHARMA LLC
as 3:2018cv16012
Defendant: SLAYBACK PHARMA LLC
Plaintiff: KYTHERA BIOPHARMACEUTICALS, INC.
Cause Of Action: 35 U.S.C. § 271
Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC We have downloadable decisions or orders for this case
as 1:2018cv01953
Defendant: Slayback Pharma LLC
Plaintiff: Eagle Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC
as 1:2018cv01459
Defendant: Slayback Pharma LLC
Plaintiff: Eagle Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. SLAYBACK PHARMA, LLC et al
as 3:2018cv14208
Defendant: SLAYBACK PHARMA INDIA LLP and SLAYBACK PHARMA, LLC
Plaintiff: KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS NORTH AMERICA LLC and others
Cause Of Action: 35 U.S.C. § 271
Biogen MA Inc. v. Slayback Pharma LLC, et al
as 1:2017cv00828
Plaintiff: Biogen MA Inc.
Defendant: Slayback Pharma LLC and Slayback Pharma India LLP
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?